sb 203580 has been researched along with eupatilin in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (eupatilin) | Trials (eupatilin) | Recent Studies (post-2010) (eupatilin) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 103 | 0 | 73 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Choi, H; Kim, CS; Kim, JH; Park, SJ | 1 |
1 other study(ies) available for sb 203580 and eupatilin
Article | Year |
---|---|
Antifibrotic effects of eupatilin on TGF-β1-treated human vocal fold fibroblasts.
Topics: Cell Death; Cell Differentiation; Cell Movement; Cell Proliferation; Collagen; Extracellular Matrix Proteins; Fibroblasts; Fibrosis; Flavonoids; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Biosynthesis; Pyridines; Smad2 Protein; Transforming Growth Factor beta1; Vocal Cords | 2021 |